 | | June 6, 2024 | Message from the Director Enhancing the stewardship and scientific rigor of clinical trials, and an update on NIDCD's May advisory council meeting  Clinical trials are at the heart of all advances in medical care. They involve prospectively assigning human participants to one or more interventions to evaluate the impact on health-related biomedical or behavioral outcomes. Findings from NIDCD clinical trials help to advance new approaches to preventing, diagnosing, and treating disorders of hearing, balance, taste, smell, voice, speech, and language that affect millions of people in the United States. In this director's message, I outline NIDCD's efforts to align with NIH stewardship policies for clinical trials, which aim to ensure that studies are well-designed and include valid endpoints so that findings are relevant, accurate, and timely. I describe tools to help applicants write successful grant applications for clinical trials, as well as resources available to grantees whose projects are funded. I also summarize topics discussed at the May meeting of the National Deafness and Other Communication Disorders Advisory Council. Read more » | | | | | | | NIDCD, part of the National Institutes of Health, supports and conducts research and research training on the normal and disordered processes of hearing, balance, taste, smell, voice, speech, and language and provides health information, based upon scientific discovery, to the public. For more information about NIDCD programs, see our website at www.nidcd.nih.gov. NIH...Turning Discovery Into Health® U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) |  
| | |
No comments:
Post a Comment